Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion
A 4-month rifampin course is an excellent option for LTBI among KTC due to its high completion rate and favorable liver safety profile; however, close monitoring for AHD interactions is essential.
Authors
- Yoichiro Natori (ORCID: https://orcid.org/0000-0002-4938-125X)
- Julia Bini Viotti (ORCID: https://orcid.org/0000-0002-8145-9440)
- Franco Cabeza
- Mariella Ortigosa‐Goggins (ORCID: https://orcid.org/0000-0001-9337-4332)
- Shweta Anjan (ORCID: https://orcid.org/0000-0002-7761-1163)
- Gaetano Ciancio (ORCID: https://orcid.org/0000-0002-0269-4152)
- Jacques Simkins (ORCID: https://orcid.org/0000-0001-9626-0760)
- Giselle Guerra (ORCID: https://orcid.org/0000-0002-4098-4652)
- Adela Mattiazzi (ORCID: https://orcid.org/0000-0002-3388-5648)
- David B. Roth (ORCID: https://orcid.org/0000-0003-3442-0022)
- Warren Kupin
- Michele I. Morris
- Javier A. Pagan
- Mahmoud Morsi
Institutions
- University of Miami (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1111/tid.70169
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00